At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Analgesics; Benzamides
- Mechanism of Action Opioid delta receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 05 Feb 2001 No-Development-Reported for Pain in United Kingdom (Unknown route)
- 22 Jan 2001 Glaxo Wellcome has merged with SmithKline Beecham to form GlaxoSmithKline
- 30 Jul 1997 New profile